The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care
Abstract
Context Peripheral arterial disease (PAD) is a manifestation of systemic atherosclerosis that is common and is associated with an increased risk of death and ischemic events, yet may be underdiagnosed in primary care practice. Objective To assess the feasibility of detecting PAD in primary care clinics, patient and physician awareness of PAD, and intensity of risk factor treatment and use of antiplatelet therapies in primary care clinics. Design and setting The PAD Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) program, a multicenter, cross-sectional study conducted at 27 sites in 25 cities and 350 primary care practices throughout the United States in June-October 1999. Patients A total of 6979 patients aged 70 years or older or aged 50 through 69 years with history of cigarette smoking or diabetes were evaluated by history and by measurement of the ankle-brachial index (ABI). PAD was considered present if the ABI was 0.90 or less, if it was documented in the medical record, or if there was a history of limb revascularization. Cardiovascular disease (CVD) was defined as a history of atherosclerotic coronary, cerebral, or abdominal aortic aneurysmal disease. Main outcome measures Frequency of detection of PAD; physician and patient awareness of PAD diagnosis; treatment intensity in PAD patients compared with treatment of other forms of CVD and with patients without clinical evidence of atherosclerosis. Results PAD was detected in 1865 patients (29%); 82…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the PAD Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) program, 30% of people aged 50-69 years with a history of cigarette smoking or diabetes, or aged $70 years regardless of risk factors, had PAD (233).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [233]
In the citing paper
“Notably, classical symptoms of claudication are uncommon, and almost half of people with newly diagnosed PAD were asymptomatic (233).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2025 (2025) · cites this paper as [233]
In the citing paper
“Notably, classical symptoms of claudication are uncommon, and almost half of people with newly diagnosed PAD were asymptomatic (223).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [223]
In the citing paper
“In the PAD Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) program, 30% of people aged 50–69 years with a history of cigarette smoking or diabetes, or aged ≥70 years regardless of risk factors, had PAD (223).”
From 10. Cardiovascular Disease and Risk Management: Standards of Care in Diabetes—2026 (2026) · cites this paper as [223]
Citations
Cites
Hulley, S. (1998) · JAMA · doi:10.1001/jama.280.7.605 · Cited by 6,216
Downs, J. R., Clearfield, M., Weis, S., Whitney, E., Shapiro, D. R., Beere, P. A., Langendorfer, A., Stein, E. A., Kruyer, W., Gotto, Jr., et al. (1998) · JAMA · doi:10.1001/jama.279.20.1615 · Cited by 5,236
Cited by
Sorted by citations
Items 201–300 of 1,042
Peripheral Arterial Disease Associated With Caries and Periodontal Disease
Soto‐Barreras, U., Olvera‐Rubio, J. O., Loyola-Rodríguez, J. P., Reyes-Macias, J. F., Martínez-Martínez, R. E., Patiño‐Marín, N., Martínez-Castañón, G. A., Aradillas-García, C., & Little, J. W. (2012) · Journal of Periodontology · doi:10.1902/jop.2012.120051 · Cited by 52
Diabetic vascular disease: characteristics of vascular disease unique to the diabetic patient.
Gibbons, G., & Shaw, P. (2012) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2012.04.005 · Cited by 57
Makowsky, M. J., McAlister, F. A., Galbraith, P. D., Southern, D. A., Ghali, W. A., Knudtson, M. L., & Tsuyuki, R. T. (2007) · American Heart Journal · doi:10.1016/j.ahj.2007.09.005 · Cited by 56
The International Pandemic of Chronic Cardiovascular Disease
McDermott, M. M. (2007) · JAMA · doi:10.1001/jama.297.11.1253 · Cited by 48
Younes, N. A., & Ahmad, A. T. (2006) · Endocrine Practice · doi:10.4158/ep.12.5.583 · Cited by 18
Applications of artificial intelligence for patients with peripheral artery disease.
Lareyre, F., Behrendt, C., Chaudhuri, A., Lee, R., Carrier, M., Adam, C., Lê, C. D., & Raffort, J. (2022) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2022.07.160 · Cited by 56
Saxon, J. T., Safley, D. M., Mena-Hurtado, C., Heyligers, J., Fitridge, R., Shishehbor, M., Spertus, J., Gosch, K., Patel, M., & Smolderen, K. (2020) · Journal of the American Heart Association : Cardiovascular and Cerebrovascular Disease · doi:10.1161/jaha.119.012541 · Cited by 56
“For tobacco cessation therapies, patients are more likely to participate in tobacco cessation programs and adhere to physician recommendations if insurance companies cover nicotine gum, etc, and overall cessation rates improved when compared with patients for whom those therapies were not covered.(21) Besides coverage…”
BackgroundWang, Z., Wang, X., Hao, G., Chen, Z., Zhang, L., Shao, L., Tian, Y., Dong, Y., Zheng, C., Kang, Y., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.10.047 · Cited by 60
McDermott, M., Ferrucci, L., Guralnik, J., Dyer, A., Liu, K., Pearce, W., Clark, E. T., Liao, Y.-H., & Criqui, M. (2010) · Vascular Medicine · doi:10.1177/1358863x10365181 · Cited by 56
Brevetti, G., Schiano, V., Sirico, G., Giugliano, G., Laurenzano, E., & Chiariello, M. (2006) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.02.048 · Cited by 55
Eason, S. L., Petersen, N. J., Suarez-Almazor, M., Davis, B., & Collins, T. C. (2005) · The Journal of the American Board of Family Medicine · doi:10.3122/jabfm.18.5.355 · Cited by 55
Paolo, N. D., Bocci, V., Salvo, D., Palasciano, F., Biagioli, M., Meini, S., Galli, F., Ciari, I., Maccari, F., Cappelletti, F., et al. (2005) · International Journal of Artificial Organs · doi:10.1177/039139880502801012 · Cited by 55
Ross, E., Jung, K., Dudley, J. T., Li, L., Leeper, N. J., & Shah, N. H. (2019) · Circulation Cardiovascular Quality and Outcomes · doi:10.1161/circoutcomes.118.004741 · Cited by 83
Lange, S., Trampisch, H., Haberl, R., Darius, H., Pittrow, D., Schuster, A., von Stritzky, B., Tepohl, G., Allenberg, J., & Diehm, C. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2004.09.003 · Cited by 54
“increasingly acknowledged in the past few years [1–5].”
BackgroundThe heart, kidney, and brain as target organs in hypertension.
Mensah, G., Croft, J., & Giles, W. (2003) · Cardiology Clinics · doi:10.1016/s0146-2806(03)00017-3 · Cited by 54
Rucker‐Whitaker, C., Greenland, P., Liu, K., Chan, C., Guralnik, J. M., Criqui, M. H., Taylor, L., Pearce, W. H., & McGraeMcDermott, M. (2004) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.2004.52259.x · Cited by 52
McBride, C. L., Akeroyd, J. M., Ramsey, D. J., Nambi, V., Nasir, K., Michos, E. D., Bush, R. L., Jneid, H. M., Morris, P. B., Bittner, V., et al. (2018) · Vascular Medicine · doi:10.1177/1358863x18758914 · Cited by 52
Focused Cardiovascular Care for Women
Garcia, M. C., Miller, V. M., Gulati, M., Hayes, S. N., Manson, J. E., WENGER, N. K., Merz, C. N. B., Mankad, R., Pollak, A. W., Mieres, J. H., et al. (2016) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.11.001 · Cited by 48
Peripheral Arterial Disease: Considerations in Risks, Diagnosis, and Treatment
Mukherjee, D., & Cho, L. (2009) · Journal of the National Medical Association · doi:10.1016/s0027-9684(15)31066-x · Cited by 45
Yang, X., Sun, K., Zhang, W., Wu, H., Zhang, H., & Hui, R.-T. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2007.03.034 · Cited by 48
Statin use and lower extremity amputation risk in nonelderly diabetic patients
Sohn, M.-W., Meadows, J. L., Oh, E. H., Budiman-Mak, E., Lee, T. A., Stone, N. J., & Pearce, W. B. (2013) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2013.06.069 · Cited by 52
Endothelial cell dysfunction: Implications for the pathogenesis of peripheral artery disease
Kavurma, M. M., Bursill, C. A., Stanley, C. P., Passam, F. H., Cartland, S. P., Patel, S., Loa, J., Figtree, G. A., Golledge, J., Aitken, S., et al. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.1054576 · Cited by 62
“, exertional leg pain in ≥1 muscle group(s), relieved by rest (5).”
BackgroundRussu, E., Mureṣan, A., Arbănași, E.-M., Kaller, R., Hosu, I., Voidăzan, S., Arbănași, E.-M., & Coșarcă, C. M. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092620 · Cited by 52
Otah, K. E., Madan, A., Otah, E., Badero, O., Clark, L., & Salifu, M. (2004) · American Journal of Cardiology · doi:10.1016/j.amjcard.2003.10.050 · Cited by 52
Micro- and Nanoparticles for Treating Cardiovascular Disease
Suarez, S. L., Almutairi, A., & Christman, K. (2015) · Biomaterials Science · doi:10.1039/c4bm00441h · Cited by 51
Paraskevas, K. I., Giannoukas, A. D., & Mikhailidis, D. P. (2009) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2009.06.002 · Cited by 50
Atherosclerotic Peripheral Vascular Disease Symposium II
Pearce, W. H., Zarins, C. K., Bacharach, J. M., & for Writing Group 6 (2008) · Circulation · doi:10.1161/circulationaha.108.191176 · Cited by 52
Renal dysfunction predicts long‐term mortality in patients with lower extremity arterial disease
Pasqualini, L., Schillaci, G., Pirro, M., Vaudo, G., Siepi, D., Innocente, S., Ciuffetti, G., & Mannarino, E. (2007) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2007.01863.x · Cited by 51
Management of Hypertension in Peripheral Arterial Disease
Buyzere, M. L. D., & Clement, D. L. (2007) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2007.08.001 · Cited by 41
Current therapies and investigational drugs for peripheral arterial disease
Suzuki, J.-I., Shimamura, M., Suda, H., Wakayama, K., Kumagai, H., Ikeda, Y., Akazawa, H., Isobe, M., Komuro, I., & Morishita, R. (2015) · Hypertension Research · doi:10.1038/hr.2015.134 · Cited by 53
Dynamic diffuse optical tomography imaging of peripheral arterial disease
Khalil, M. A., Kim, H. K., Kim, I.-K., Flexman, M., Dayal, R., Shrikhande, G., & Hielscher, A. (2012) · Biomedical Optics Express · doi:10.1364/boe.3.002288 · Cited by 50
Peripheral and cerebrovascular atherosclerotic disease in diabetes mellitus.
Mukherjee, D. (2009) · Best practice & research. Clinical endocrinology & metabolism · doi:10.1016/j.beem.2008.10.015 · Cited by 50
Screening for peripheral arterial disease.
Andras, A., & Ferket, B. S. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010835.pub2 · Cited by 49
The PANDORA study: peripheral arterial disease in patients with non-high cardiovascular risk
Cimminiello, C., Kownator, S., Wautrecht, J., Carvounis, C., Kranendonk, S. E., Kindler, B., Mangrella, M., Borghi, C., & F. T. A. Investigators (2011) · Internal and Emergency Medicine · doi:10.1007/s11739-011-0511-0 · Cited by 48
“According to recommendations that are mainly derived from the PARTNERS (PAD Awareness, Risk, and Treatment: New Resources for Survival) study, these patients should be assessed for asymptomatic PAD [ 21 ].”
MethodEnfermedad arterial periférica: aspectos fisiopatológicos, clínicos y terapéuticos
Hernando, F. J. S., & Conejero, A. M. (2007) · Revista Española de Cardiología · doi:10.1157/13109651 · Cited by 102
Bridgwood, B. M., Nickinson, A., Houghton, J. S. M., Pepper, C., & Sayers, R. D. (2020) · Vascular Medicine · doi:10.1177/1358863x19893003 · Cited by 68
Development of a multicenter peripheral arterial interventional database: the PVD-QI2.
Mukherjee, D., Munir, K., Hirsch, A., Chetcuti, S., Grossman, P., Rajagopalan, S., Nallamothu, B., Moscucci, M., Henke, P., Kassab, E. H., et al. (2005) · American Heart Journal · doi:10.1016/j.ahj.2004.08.015 · Cited by 47
Self-citationHira, R. S., Cowart, J. B., Akeroyd, J. M., Ramsey, D., Pokharel, Y., Nambi, V., Jneid, H., Deswal, A., Denktas, A., Taylor, A. A., et al. (2016) · American Journal of Cardiology · doi:10.1016/j.amjcard.2016.07.027 · Cited by 46
Management of peripheral arterial disease in chronic kidney disease.
O'Hare, A. (2005) · Cardiology Clinics · doi:10.1016/j.ccl.2005.03.006 · Cited by 46
“90 [25].”
BackgroundPeripheral arterial disease: pathophysiology, risk factors, and role of antithrombotic therapy.
Bradberry, J. (2004) · Journal of the American Pharmacists Association · doi:10.1331/154434504322904596 · Cited by 46
Low lifetime recreational activity is a risk factor for peripheral arterial disease
Wilson, A. M., Sadrzadeh-Rafie, A. H., Myers, J., Assimes, T., Nead, K. T., Higgins, M., Gabriel, A., Olin, J., & Cooke, J. P. (2011) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2011.02.052 · Cited by 45
Characterizing the Geographic Distribution of Vascular Surgeons in the United States.
Potluri, V. K., Bilello, J., Patel, S. G., Yarra, S., Sykes, M. T., & Silva, M. B. (2022) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2022.09.015 · Cited by 45
Clinical validation of smartphone-based activity tracking in peripheral artery disease patients
Ata, R., Gandhi, N., Rasmussen, H., El-Gabalawy, O., Gutierrez, S., Ahmad, A., Suresh, S., Ravi, R., Rothenberg, K. A., & Aalami, O. O. (2018) · npj Digital Medicine · doi:10.1038/s41746-018-0073-x · Cited by 45
Patel, K., Jones, P. G., Ellerbeck, E. F., Buchanan, D. M., Chan, P. S., Pacheco, C. M., Moneta, G. L., Spertus, J. A., & Smolderen, K. G. E. (2018) · Journal of the American Heart Association · doi:10.1161/jaha.118.010076 · Cited by 60
“16,17,28,29 The global REACH (Reduction of Atherothrombosis for Continued Health) registry found that 22% of patients with PAD were current smokers, a prevalence almost double that of patients with other forms of atherosclerotic disease.”
Maeda, Y., Inoguchi, T., Tsubouchi, H., Sawada, F., Sasaki, S., Fujii, M., Saito, R., Yanase, T., Shimabukuro, M., Nawata, H., et al. (2008) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2008.09.008 · Cited by 43
Bianchi, C., Montalvo, V., Ou, H. W., Bishop, V., & Abou-Zamzam, A. (2007) · Annals of Vascular Surgery · doi:10.1016/j.avsg.2007.01.008 · Cited by 45
McDermott, M., Tiukinhoy, S. D., Greenland, P., Liu, K., Pearce, W., Guralnik, J., Unterreiner, S., Gluckman, T., Criqui, M., & Ferrucci, L. (2004) · Journal of Cardiopulmonary Rehabilitation (JCR) · doi:10.1097/00008483-200405000-00010 · Cited by 45
Effects of passive smoking on coronary circulation.
Volpi, E., Rasmussen, B., Sheffield-Moore, M., & Wolfe, R. R. (2002) · JAMA · doi:10.1001/jama.287.3.313 · Cited by 45
Trends in peripheral arterial disease incidence and mortality in EU15+ countries 1990-2017.
Goodall, R., Salciccioli, J., Davies, A., Marshall, D., & Shalhoub, J. (2019) · European Journal of Preventive Cardiology · doi:10.1016/j.ejvs.2019.09.031 · Cited by 44
Interpretation and significance of ankle-brachial systolic pressure index.
Ko, S., & Bandyk, D. (2013) · Seminars in Vascular Surgery · doi:10.1053/j.semvascsurg.2014.01.002 · Cited by 44
“The PAD Awareness, Risk, and Treatment: New Resources for Survival (PARTNERS) program, a multicenter, crosssectional study conducted in 1999 at 27 sites in 25 cities and 350 primary care practices documented a disease prevalence of 29% based on ABI testing [13].”
BackgroundInfluentialType D Personality and Mortality in Peripheral Arterial Disease: A Pilot Study
Aquarius, A. E. (2009) · Archives of Surgery · doi:10.1001/archsurg.2009.75 · Cited by 43
Sprengers, R. W., Janssen, K. J. M., Moll, F. L., Verhaar, M. C., & van der Graaf, Y. (2009) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2009.07.095 · Cited by 43
Ueshima, D., Barioli, A., Fovino, L. N., D’Amico, G., Fabris, T., Brener, S., & Tarantini, G. (2020) · Catheterization and cardiovascular interventions · doi:10.1002/ccd.28335 · Cited by 43
Ferreira, A., & Macedo, F. Y. B. (2010) · Annals of Medicine · doi:10.3109/07853890903521070 · Cited by 43
Therapeutic Options for Diabetic Foot Infections
Nicolau, D. P., & Stein, G. E. (2010) · Journal of the American Podiatric Medical Association · doi:10.7547/1000052 · Cited by 38
Fereydooni, A., Gorecka, J., & Dardik, A. (2019) · Vascular Medicine · doi:10.1177/1358863x19878271 · Cited by 47
Yuan, O., Lin, C., Wagner, J., Anderson, J. S., Archard, J. A., Deng, P., Halmai, J. A. N. M., Bauer, G., Fink, K. D., Fury, B., et al. (2019) · Stem Cells and Development · doi:10.1089/scd.2018.0200 · Cited by 53
Baerlocher, M., Kennedy, S., Rajebi, M., Baerlocher, F., Misra, S., Liu, D. M., & Nikolic, B. (2015) · Journal of Vascular and Interventional Radiology · doi:10.1016/j.jvir.2014.12.013 · Cited by 42
Detection of peripheral arterial disease in primary care.
Ouriel, K. (2001) · Journal of the American Medical Association (JAMA) · doi:10.1001/jama.286.11.1380 · Cited by 42
Rammos, C., Steinmetz, M., Lortz, J., Mahabadi, A. A., Petrikhovich, O., Kirsch, K., Hering, R., Schulz, M., & Rassaf, T. (2021) · The Lancet Regional Health - Europe · doi:10.1016/j.lanepe.2021.100113 · Cited by 54
“The Peripheral Arterial Disease Awareness Risk and Treatment: New Resources for Survival (PARTNERS) program previously showed a distinct discrepancy between the high prevalence of PAD and the low awareness of the PAD diagnosis in the primary care setting in the US [19].”
BackgroundWeissler, E., Zhang, J.-K., Lippmann, S. J., Rusincovitch, S. A., Henao, R., & Jones, W. (2020) · Circulation. Cardiovascular Interventions · doi:10.1161/circinterventions.120.009447 · Cited by 41
Baltgalvis, K. A., White, K., Li, W., Claypool, M. D., Lang, W., Alcantara, R. R., Singh, B., Friera, A. M., McLaughlin, J. R., Hansen, D., et al. (2014) · American Journal of Physiology. Heart and Circulatory Physiology · doi:10.1152/ajpheart.00839.2013 · Cited by 41
Association of ankle-brachial index level with stroke.
Ovbiagele, B. (2009) · Journal of Neurological Sciences · doi:10.1016/j.jns.2008.08.016 · Cited by 41
“Furthermore, the prevalence of PAD is substantially higher in persons 55 years and above, as noted previously [1].”
BackgroundInfluentialBianchi, C., Penno, G., Pancani, F., Civitelli, A., Piaggesi, A., Caricato, F., Pellegrini, G., Prato, S. D., & Miccoli, R. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.03.020 · Cited by 41
Diagnostic value of carotid intima-media thickness in indicating multi-level atherosclerosis.
Kabłak-Ziembicka, A., Przewłocki, T., Tracz, W., Pienia̧žek, P., Musialek, P., Stopa, I., Zalewski, J., & Żmudka, K. (2007) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2006.07.005 · Cited by 41
Complementary therapies for peripheral arterial disease: systematic review.
Pittler, M., & Ernst, E. (2005) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2005.02.021 · Cited by 41
“Peripheral arterial disease (PAD) affects a considerable proportion of the general population and is a prevalent condition in the primary care setting [1–3].”
BackgroundMa, K. F., Kleiss, S. F., Schuurmann, R. C. L., Bokkers, R. P. H., Ünlü, Ç., & de Vries, J. P. P. M. (2019) · Expert Review of Medical Devices · doi:10.1080/17434440.2019.1644166 · Cited by 54
Hart, C., Layec, G., Trinity, J., Fur, Y. L., Gifford, J., Clifton, H. L., & Richardson, R. (2018) · American Journal of Physiology. Heart and Circulatory Physiology · doi:10.1152/ajpheart.00641.2017 · Cited by 40
Saleh, A., Makhamreh, H., Qoussoos, T., AlAwwa, I., Alsmady, M., Salah, Z. A., Shakhatreh, A., Alhazaymeh, L., & Jabber, M. (2018) · Medicine · doi:10.1097/md.0000000000011519 · Cited by 46
Ruifrok, W.-P. T., de Boer, R. A., Iwakura, A., Silver, M., KUSANO, K. F., Tio, R. A., & Losordo, D. W. (2009) · Vascular Medicine · doi:10.1177/1358863x08096666 · Cited by 44
Luo, Y.-Y., Li, J., Xin, Y., Zheng, L.-Q., Yu, J.-M., & Hu, D. (2007) · Journal of Human Hypertension · doi:10.1038/sj.jhh.1002177 · Cited by 40
Goessens, B. M. B., van der Graaf, Y., Olijhoek, J. K., & Visseren, F. L. J. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.09.015 · Cited by 36
Epidemiology and pathophysiology of peripheral arterial disease.
Levy, P. (2002) · Clinical Cornerstone · doi:10.1016/s1098-3597(02)90012-8 · Cited by 40
“PARTNERS Program ( 1 ) 1865 History — History — 56 TABLE 1. PREVALENCE OF CVD (CAD, CeVD) IN PATIENTS WITH PAD”
BackgroundInfluentialFitridge, R., Chuter, V., Mills, J. L., Hinchliffe, R. J., Azuma, N., Behrendt, C., Boyko, E. J., Conte, M. S., Humphries, M. D., Kirksey, L., et al. (2023) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2023.07.020 · Cited by 78
Fort-Gallifa, I., García-Heredia, A., Hernández-Aguilera, A., Simó, J. M., Sepulveda, J. N., Martín‐Paredero, V., Camps, J., & Joven, J. (2016) · Free Radical Biology & Medicine · doi:10.1016/j.freeradbiomed.2016.07.011 · Cited by 39
Statins and Peripheral Arterial Disease: A Narrative Review
Jansen‐Chaparro, S., Lopez-Carmona, M. D., Cobos-Palacios, L., Sanz‐Cánovas, J., Bernal-López, M. R., & Gómez‐Huelgas, R. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.777016 · Cited by 50
Jalkanen, J., Maksimow, M., Hollmén, M., Jalkanen, S., & Hakovirta, H. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162353 · Cited by 38
The association of obesity with cardiovascular events in patients with peripheral artery disease.
Cronin, O., Morris, D., Walker, P., & Golledge, J. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.03.002 · Cited by 38
Gestational diabetes and subclinical inflammation: Evaluation of first year postpartum outcomes
Özuğuz, U., Işık, S., Berker, D. S., Arduç, A., Tütüncü, Y., Akbaba, G., Gökay, F., & Güler, S. (2011) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2011.08.024 · Cited by 34
“, higher CIMT values were reported in association with GDM [33], although a possible role of subclinical inflammation was not evaluated.”
BackgroundArain, F. A., Khaleghi, M., Bailey, K. R., Lahr, B. D., Rooke, T. W., & Kullo, I. J. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.02.020 · Cited by 39
The US experience with cilostazol in treating intermittent claudication.
Hiatt, W. (2005) · Atherosclerosis Supplements · doi:10.1016/j.atherosclerosissup.2005.09.004 · Cited by 38
Bonham, P. (2006) · Journal of Wound, Ostomy and Continence Nursing (WOCN) · doi:10.1097/00152192-200601000-00004 · Cited by 38
Barraclough, J. Y., Yu, J., Figtree, G. A., Perkovic, V., Heerspink, H. J. L., Neuen, B. L., Cannon, C. P., Mahaffey, K. W., Schutte, A. E., Neal, B., et al. (2022) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.14671 · Cited by 37
Collins, T. C., Slovut, D. P., Newton, R., Johnson, W. D., Larrivee, S., Patterson, J., Johnston, J. A., & Correa, A. (2017) · Preventive Medicine Reports · doi:10.1016/j.pmedr.2017.05.005 · Cited by 36
Effectiveness of Blood Lipid Management in Patients With Peripheral Artery Disease
Hess, C. N., Cannon, C. P., Beckman, J. A., Goodney, P. P., Patel, M. R., Hiatt, W. R., Mues, K. E., Orroth, K. K., Shannon, E., & Bonaca, M. P. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.060 · Cited by 54
Patel, S. I., Chakkera, H. A., Wennberg, P. W., Liedl, D., Alrabadi, F., Cha, S. S., Hooley, D. D., Amer, H., Wadei, H. M., & Shamoun, F. E. (2017) · Vascular Medicine · doi:10.1177/1358863x16689830 · Cited by 40
Rafie, A. H. S., Stefanick, M. L., Sims, S. T., Phan, T., Higgins, M., Gabriel, A., Assimes, T. L., Narasimhan, B., Nead, K. T., MYERS, J. N., et al. (2010) · Vascular Medicine · doi:10.1177/1358863x10388345 · Cited by 36
Sprengers, R. W., Moll, F. L., & Verhaar, M. C. (2010) · European Journal of Vascular and Endovascular Surgery · doi:10.1016/j.ejvs.2009.12.001 · Cited by 34
Stroke with polyvascular atherothrombotic disease
Blanco, M., Sobrino, T., Montaner, J., Medrano, V., Jiménez, C., Masjuán, J., Gómez-Escalonilla, C., de Luis, P., Arboix, A., & Castillo, J. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.07.041 · Cited by 39
“1 [0, 3] 0.”
BackgroundManzano, L., Mostaza, J., Suárez, C., Cairols, M., Redondo, R., Valdivielso, P., Monte, R., Blázquez, J., Ferreira, E., Trouillhet, I., et al. (2007) · doi:10.1157/13099239 · Cited by 37
The heart, kidney, and brain as target organs in hypertension
Mensah, G. A., Croft, J. B., & Giles, W. H. (2002) · Cardiology Clinics · doi:10.1016/s0733-8651(02)00004-8 · Cited by 74
“It must be emphasized that classic claudication is not commonly elicited from the clinical history even in patients with established peripheral arterial disease [132].”
BackgroundInfluentialLin, S.-Y., Lin, C., Lin, C., Wang, I., Hsu, W., & Kao, C. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.01.047 · Cited by 35
Endovascular treatment of lower extremity peripheral arterial disease
Klein, A. J., & Ross, C. B. (2016) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2016.02.007 · Cited by 39
Comprehensive Endovascular Therapy for Femoropopliteal Arterial Atherosclerotic Occlusive Disease
Davies, M. G., Waldman, D. L., & Pearson, T. A. (2005) · Journal of the American College of Surgeons · doi:10.1016/j.jamcollsurg.2005.03.007 · Cited by 34
Muhs, B., Gagne, P., & Sheehan, P. (2005) · Current Diabetes Reports · doi:10.1007/s11892-005-0063-7 · Cited by 36
“The PARTNERS (PAD Awareness, Risk, and Treatment: New Resources for Survival) study recently showed that the prevalence of PAD in patients with diabetes was much greater than anticipated, with an estimated 29% of patients with diabetes over age 50 being afflicted [ 3 ].”
BackgroundCollins, T. C., Suarez-Almazor, M., Petersen, N., & O'Malley, K. (2004) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2004.03.005 · Cited by 36
van Weel, V., Deckers, M. M. L., Grimbergen, J. M., van Leuven, K., Lardenoye, J.-W. H. P., Schlingemann, R. O., Amerongen, G. P. V. N., van Bockel, J. H., van Hinsbergh, V. W. M., & Quax, P. H. A. (2004) · Circulation Research · doi:10.1161/01.res.0000133247.69803.c3 · Cited by 73
Fatty acid binding protein 3 is associated with peripheral arterial disease
Syed, M., Zamzam, A., Khan, H., Singh, K., Forbes, T., Rotstein, O., Abdin, R., Eikelboom, J., & Qadura, M. (2020) · JVS: Vascular Science · doi:10.1016/j.jvssci.2020.08.003 · Cited by 35
Peripheral Arterial Disease in Women: The Gender Effect
Patel, T., Baydoun, H., Patel, N. K., Tripathi, B., Nanavaty, S. P., Savani, S., Mojadidi, M. K., Agarwal, N., Patel, G., Patel, S., et al. (2019) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2019.05.026 · Cited by 53
Recruitment and therapeutic application of macrophages in skeletal muscles after hind limb ischemia
Hsieh, P.-L., Rybalko, V. Y., Baker, A., Suggs, L., & Farrar, R. (2017) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2017.04.070 · Cited by 35
Metadata
- Authors
- Hirsch, A. T.
- Affiliations
- University of Minnesota (US)
- Corresponding author
- Hirsch, Alan T.
- Venue
- JAMA
- Publisher
- American Medical Association (AMA)
- Published
- 2001-09-19
- Volume
- 286
- Issue
- 11
- Pages
- 1317
- ISSN
- 0002-9955 (ISSN-L)
- 0098-7484
- OpenAlex
- W2140136269
- Cited by
- 2,835
- References
- 0
- Citations by year
- 2026: 59 · 2025: 77 · 2024: 89 · 2023: 102 · 2022: 113 · 2021: 127 · 2020: 100 · 2019: 105 · 2018: 147 · 2017: 105 · 2016: 135 · 2015: 122 · 2014: 160 · 2013: 145 · 2012: 166
- FWCI
- 62.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- JAMA (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5k07hl003435-05)
- National Heart, Lung, and Blood Institute (1-K07-HL03435-01)
- Topics
- Health Sciences › Medicine › Surgery › Peripheral Artery Disease Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Vascular Procedures and Complications
- Keywords
- peripheral arterial disease, ankle-brachial index, underdiagnosis, patient awareness, physician awareness, cardiovascular disease, atherosclerosis, antiplatelet therapy, smoking cessation, diabetes mellitus, intermittent claudication, primary care, older adults, limb revascularization, cardiovascular risk stratification, diabetes self-management education
- MeSH terms
- Aged, Arteriosclerosis, Cardiovascular Diseases, Cross-Sectional Studies, Family Practice, Female, Humans, Intermittent Claudication, Health Knowledge, Attitudes, Practice, Male, Middle Aged, Platelet Aggregation Inhibitors, Risk Factors, Ultrasonography, Doppler
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
